JP2023521744A5 - - Google Patents

Info

Publication number
JP2023521744A5
JP2023521744A5 JP2022561206A JP2022561206A JP2023521744A5 JP 2023521744 A5 JP2023521744 A5 JP 2023521744A5 JP 2022561206 A JP2022561206 A JP 2022561206A JP 2022561206 A JP2022561206 A JP 2022561206A JP 2023521744 A5 JP2023521744 A5 JP 2023521744A5
Authority
JP
Japan
Prior art keywords
agent according
agent
substance
peptide
permeability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022561206A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521744A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2021/050223 external-priority patent/WO2021206547A1/en
Publication of JP2023521744A publication Critical patent/JP2023521744A/ja
Publication of JP2023521744A5 publication Critical patent/JP2023521744A5/ja
Priority to JP2025187819A priority Critical patent/JP2026027378A/ja
Pending legal-status Critical Current

Links

JP2022561206A 2020-04-06 2021-04-06 感染症における血行動態を変更する為の方法及び手段 Pending JP2023521744A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025187819A JP2026027378A (ja) 2020-04-06 2025-11-06 感染症における血行動態を変更する為の方法及び手段

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063005999P 2020-04-06 2020-04-06
US63/005,999 2020-04-06
US202063045737P 2020-06-29 2020-06-29
US63/045,737 2020-06-29
US202063085771P 2020-09-30 2020-09-30
US63/085,771 2020-09-30
PCT/NL2021/050223 WO2021206547A1 (en) 2020-04-06 2021-04-06 Methods and means for modifying hemodynamics in infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025187819A Division JP2026027378A (ja) 2020-04-06 2025-11-06 感染症における血行動態を変更する為の方法及び手段

Publications (2)

Publication Number Publication Date
JP2023521744A JP2023521744A (ja) 2023-05-25
JP2023521744A5 true JP2023521744A5 (https=) 2024-04-11

Family

ID=75581581

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022561206A Pending JP2023521744A (ja) 2020-04-06 2021-04-06 感染症における血行動態を変更する為の方法及び手段
JP2025187819A Pending JP2026027378A (ja) 2020-04-06 2025-11-06 感染症における血行動態を変更する為の方法及び手段

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025187819A Pending JP2026027378A (ja) 2020-04-06 2025-11-06 感染症における血行動態を変更する為の方法及び手段

Country Status (9)

Country Link
US (1) US20230241155A1 (https=)
EP (1) EP4132556A1 (https=)
JP (2) JP2023521744A (https=)
KR (1) KR20230003495A (https=)
AU (1) AU2021252821A1 (https=)
CA (1) CA3174852A1 (https=)
CO (1) CO2022015018A2 (https=)
MX (1) MX2022012506A (https=)
WO (1) WO2021206547A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4021481A1 (en) * 2019-08-30 2022-07-06 Biotempt B.V. Q-er peptide
AU2021354766A1 (en) * 2020-09-30 2023-05-11 Biotempt B.V. Autophagy-inhibiting peptide and organic acid salt thereof addressing issues of vascular permeability
WO2025191033A1 (en) 2024-03-13 2025-09-18 Biotempt B.V. Per-operative treatment of post-operative complications (poc)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542791A (en) * 2003-04-08 2008-04-30 Biotempt Bv Compositions for mucosal and oral administration comprising HCG fragments
EP4021481A1 (en) * 2019-08-30 2022-07-06 Biotempt B.V. Q-er peptide
CA3152346A1 (en) * 2019-09-30 2021-04-08 Roelof Peter Pickkers Methods of treatment for modifying hemodynamics

Similar Documents

Publication Publication Date Title
JP2023521744A5 (https=)
Haraldsson et al. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study
ES3057264T3 (en) 5-amino-2,3-dihydro-1,4-phthalazinedione for use in the treatment of coronaviral infections
JP2023534524A5 (https=)
EP3906922A1 (en) New compositions and methods of treating covid-19 disease
JP2015508771A5 (https=)
JP2026027378A5 (https=)
JP2024517334A (ja) コロナウイルス疾患（ｃｏｖｉｄ－１９）における急性呼吸窮迫症候群（ａｒｄｓ）の治療のための医薬組成物及び方法
JP2023517616A (ja) 急性呼吸窮迫症候群およびウイルス感染の治療用のｃｘｃｒ４阻害剤
Harfouch et al. Therapeutic approaches for COVID 19: Challenges and successes
JP7840570B2 (ja) コロナウイルス感染症の処置のための方法
RU2417083C2 (ru) Применение активаторов растворимой гуанилатциклазы для лечения острых и хронических легочных заболеваний
US11497747B2 (en) Compositions and methods for treating lung injuries associated with SARS-CoV-2 infections
WO2004103399A1 (fr) Utilisation d'ulinastatine pour traiter le syndrome respiratoire aigu et composition pharmaceutique contenant ulinastatine
RU2009104356A (ru) Перфторуглеродная эмульсия с коллоидным серебром для медико-биологических и косметических целей: состав и средство для применения
WO2008004653A1 (en) Prophylactic or therapeutic agent for viral disease
CN110494135A (zh) 包含扎那米韦的稳定的药剂学组合物
JP2006503049A5 (https=)
Georgiyants et al. Current conception about the pathogenesis and intensive care of severe COVID-19
Ashique et al. A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с
JP2024518530A (ja) ウイルス感染の予防及び治療のための二環式複素環化合物
JP2008533102A5 (https=)
US20220304959A1 (en) Treatment of long haulers syndrome with niclosamide
Hameed et al. Recent Developments in Therapies and Strategies Against COVID-19